688136.SH
科兴制药
SSE · Healthcare · Biotechnology · CN
CNY 23.60
+14.84%Margins
Gross margin
61.4%
EBITDA margin
18.6%
EBIT margin
7.4%
Net margin
7.7%
FCF margin
-1.4%
6.5%
Return on equity
3.2%
Return on assets
4.2%
Return on invested capital
0.42x
Asset turnover
CNY 67.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026